ArticleComputational and structural biotechnology journal2022

Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers.

Ning Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.